Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > ISOMERASE THERAPEUTICS LIMITED
Company Information for

ISOMERASE THERAPEUTICS LIMITED

FIRST FLOOR NEWNHAM BUILDING, CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, CAMBRIDGE, CB10 1XL,
Company Registration Number
08335008
Private Limited Company
Active

Company Overview

About Isomerase Therapeutics Ltd
ISOMERASE THERAPEUTICS LIMITED was founded on 2012-12-18 and has its registered office in Cambridge. The organisation's status is listed as "Active". Isomerase Therapeutics Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
ISOMERASE THERAPEUTICS LIMITED
 
Legal Registered Office
FIRST FLOOR NEWNHAM BUILDING
CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD
CAMBRIDGE
CB10 1XL
Other companies in CB10
 
Filing Information
Company Number 08335008
Company ID Number 08335008
Date formed 2012-12-18
Country UNITED KINGDOM
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/12/2023
Account next due 30/09/2025
Latest return 31/10/2015
Return next due 28/11/2016
Type of accounts SMALL
Last Datalog update: 2024-12-05 10:15:30
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for ISOMERASE THERAPEUTICS LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of ISOMERASE THERAPEUTICS LIMITED

Current Directors
Officer Role Date Appointed
ROBERT ALEC BOOTH
Director 2013-03-21
MATTHEW ALAN GREGORY
Director 2012-12-18
STEVEN JAMES MOSS
Director 2012-12-18
BARRIE WILKINSON
Director 2012-12-18

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
ROBERT ALEC BOOTH FOUNDRIES.IO LIMITED Director 2017-08-04 CURRENT 2017-08-04 Active
ROBERT ALEC BOOTH CFO-PLUS LIMITED Director 2012-03-13 CURRENT 2012-03-13 Active
ROBERT ALEC BOOTH GENERIC ASSAYS LIMITED Director 2006-04-25 CURRENT 2006-04-25 Dissolved 2016-05-17
ROBERT ALEC BOOTH ADVANCED QA SOLUTIONS LIMITED Director 2003-10-13 CURRENT 2003-10-13 Active - Proposal to Strike off

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-11-07CONFIRMATION STATEMENT MADE ON 31/10/24, WITH UPDATES
2024-10-0201/10/24 STATEMENT OF CAPITAL GBP 8984.51
2024-09-16SMALL COMPANY ACCOUNTS MADE UP TO 31/12/23
2024-09-06Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul>
2024-07-2322/07/24 STATEMENT OF CAPITAL GBP 8892.21
2024-04-29APPOINTMENT TERMINATED, DIRECTOR SIMON ERIC ASPLAND
2024-02-1413/02/24 STATEMENT OF CAPITAL GBP 8882.21
2023-10-11SMALL COMPANY ACCOUNTS MADE UP TO 31/12/22
2023-10-0412/09/23 STATEMENT OF CAPITAL GBP 8874.96
2023-05-2215/05/23 STATEMENT OF CAPITAL GBP 8864.96
2022-10-1004/10/22 STATEMENT OF CAPITAL GBP 8767.96
2022-03-17AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/21
2021-11-01CS01CONFIRMATION STATEMENT MADE ON 31/10/21, WITH UPDATES
2021-08-10AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/20
2021-07-21SH0128/06/21 STATEMENT OF CAPITAL GBP 8676.81
2021-02-16SH0111/02/21 STATEMENT OF CAPITAL GBP 8615.66
2020-11-24SH0118/11/20 STATEMENT OF CAPITAL GBP 8569.51
2020-11-12CS01CONFIRMATION STATEMENT MADE ON 31/10/20, WITH UPDATES
2020-11-12CH01Director's details changed for Dr Steven James Moss on 2020-10-23
2020-11-12PSC04Change of details for Dr Steven James Moss as a person with significant control on 2020-10-23
2020-10-16SH0128/09/20 STATEMENT OF CAPITAL GBP 8513.36
2020-08-28AD01REGISTERED OFFICE CHANGED ON 28/08/20 FROM Suite 4 - First Floor Newnham Building Chesterford Research Park, Little Chesterford Cambridge CB10 1XL United Kingdom
2020-08-27AD01REGISTERED OFFICE CHANGED ON 27/08/20 FROM Suite 9 Science Village Chesterford Research Park Cambridge CB10 1XL
2020-08-05AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/19
2020-07-10SH0116/06/20 STATEMENT OF CAPITAL GBP 8508.36
2019-10-31CS01CONFIRMATION STATEMENT MADE ON 31/10/19, WITH UPDATES
2019-09-30SH0111/09/19 STATEMENT OF CAPITAL GBP 8504.36
2019-09-30RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of allotment of securities
2019-05-31AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/18
2018-11-02CS01CONFIRMATION STATEMENT MADE ON 31/10/18, WITH UPDATES
2018-11-02CH01Director's details changed for Barrie Wilkinson on 2018-11-02
2018-10-31PSC04Change of details for Matthew Alan Gregory as a person with significant control on 2016-04-06
2018-10-03AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/17
2017-11-01LATEST SOC01/11/17 STATEMENT OF CAPITAL;GBP 8444.36
2017-11-01CS01CONFIRMATION STATEMENT MADE ON 31/10/17, WITH UPDATES
2017-10-31CH01DIRECTOR'S CHANGE OF PARTICULARS / BARRIE WILKINSON / 19/10/2017
2017-10-31PSC09Withdrawal of a person with significant control statement on 2017-10-31
2017-10-31CH01DIRECTOR'S CHANGE OF PARTICULARS / DR STEVEN JAMES MOSS / 19/10/2017
2017-10-31PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL STEVEN JAMES MOSS
2017-10-25CH01Director's details changed for Matthew Alan Gregory on 2017-10-25
2017-10-19PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL MATTHEW ALAN GREGORY
2017-10-19CH01Director's details changed for Matthew Alan Gregory on 2017-10-19
2017-10-06AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/16
2016-11-02LATEST SOC02/11/16 STATEMENT OF CAPITAL;GBP 8444.36
2016-11-02CS01CONFIRMATION STATEMENT MADE ON 31/10/16, WITH UPDATES
2016-09-29AA31/12/15 ACCOUNTS TOTAL EXEMPTION SMALL
2015-11-02LATEST SOC02/11/15 STATEMENT OF CAPITAL;GBP 8444.36
2015-11-02AR0131/10/15 ANNUAL RETURN FULL LIST
2015-10-03AA31/12/14 ACCOUNTS TOTAL EXEMPTION SMALL
2015-01-06LATEST SOC06/01/15 STATEMENT OF CAPITAL;GBP 8444.36
2015-01-06SH0112/11/14 STATEMENT OF CAPITAL GBP 8444.36
2014-12-09AR0131/10/14 ANNUAL RETURN FULL LIST
2014-09-22AA31/12/13 ACCOUNTS TOTAL EXEMPTION SMALL
2014-01-17SH0130/11/13 STATEMENT OF CAPITAL GBP 8273.85
2013-12-20AR0131/10/13 ANNUAL RETURN FULL LIST
2013-06-13AD01REGISTERED OFFICE CHANGED ON 13/06/13 FROM Mfg Solicitors Adam House Birmingham Road Kidderminster Worcs DY10 2SH England
2013-05-23AP01DIRECTOR APPOINTED MR ROBERT ALEC BOOTH
2013-05-14SH0104/04/13 STATEMENT OF CAPITAL GBP 7230.77
2013-04-10SH0115/03/13 STATEMENT OF CAPITAL GBP 6000.00
2013-04-10SH02SUB-DIVISION 26/02/13
2013-01-30CH01DIRECTOR'S CHANGE OF PARTICULARS / BARRIE WILKINSON / 30/01/2013
2013-01-30CH01DIRECTOR'S CHANGE OF PARTICULARS / STEVEN JAMES MOSS / 30/01/2013
2013-01-30CH01DIRECTOR'S CHANGE OF PARTICULARS / MATTHEW ALAN GREGORY / 30/01/2013
2012-12-18NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to ISOMERASE THERAPEUTICS LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against ISOMERASE THERAPEUTICS LIMITED
SELECT CourtName,CaseID,CONCAT('',MIN(Date),' to ',MAX(Date),'') AS Date,CaseText,JudgeName,CaseDescriptor,count(*) as NumRecords FROM legal_court_dates where PlaintiffCompanyNumber='08335008' OR DefendantCompanyNumber='08335008' GROUP BY CaseID
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
ISOMERASE THERAPEUTICS LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Intangible Assets
Patents
We have not found any records of ISOMERASE THERAPEUTICS LIMITED registering or being granted any patents
Domain Names

Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /srv/www/htdocs/datalog/browse/detail.php on line 3481
We do not have the domain name information for ISOMERASE THERAPEUTICS LIMITED
Trademarks
select Authority, B.Date AS Date, C.TrademarkID AS TrademarkID, C.RegistrationID AS RegistrationID, A.CompanyName AS Assignor, D.CompanyName AS Assignee, D.Nationality AS Nationality, D.CompanyNUmber AS AssigneeCoNum, TEXT from trademark_companies AS A left join trademark_assignments AS B ON A.CompanyID=B.AssignorID LEFT JOIN trademarks AS C ON B.TrademarkID=C.TrademarkID LEFT JOIN trademark_companies AS D ON B.AssigneeID=D.CompanyID WHERE A.CompanyNumber='08335008' AND B.TrademarkID IS NOT NULL ORDER BY TrademarkID DESC
Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /srv/www/htdocs/datalog/browse/detail.php on line 3578
select Authority, B.Date AS Date, C.TrademarkID AS TrademarkID, C.RegistrationID AS RegistrationID, A.CompanyName AS Assignor, D.CompanyName AS Assignee, D.Nationality AS Nationality, D.CompanyNUmber AS AssigneeCoNum, TEXT from trademark_companies AS A left join trademark_assignments AS B ON A.CompanyID=B.AssigneeID LEFT JOIN trademarks AS C ON B.TrademarkID=C.TrademarkID LEFT JOIN trademark_companies AS D ON B.AssignorID=D.CompanyID WHERE A.CompanyNumber='08335008' AND B.TrademarkID IS NOT NULL ORDER BY Date DESC
Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /srv/www/htdocs/datalog/browse/detail.php on line 3616
We have not found any records of ISOMERASE THERAPEUTICS LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for ISOMERASE THERAPEUTICS LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as ISOMERASE THERAPEUTICS LIMITED are:

SELECT MD5(concat(contract_authority_official_name,contract_operator_official_name, document_title_text,contract_contract_award_year,contract_contract_award_year,contract_contract_description)) AS HASH, TED.* FROM TED WHERE SupplierCompanyNumber='08335008' GROUP BY HASHSELECT MD5(concat(contract_authority_official_name,contract_operator_official_name, document_title_text,contract_contract_award_year,contract_contract_award_year,contract_contract_description)) AS HASH, TED.* FROM TED WHERE PurchaserCompanyNumber ='08335008' GROUP BY HASH
Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /srv/www/htdocs/datalog/browse/detail.php on line 1489

Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /srv/www/htdocs/datalog/browse/detail.php on line 1489
Outgoings
Business Rates/Property Tax
No properties were found where ISOMERASE THERAPEUTICS LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by ISOMERASE THERAPEUTICS LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2018-08-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-04-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-01-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2017-03-0029141100Acetone
2017-03-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-11-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-11-0029420000Separate chemically defined organic compounds, n.e.s.
2016-10-0030049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2016-09-0030049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2016-09-0030059099Bandages and similar articles impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes (excl. those of textile materials, adhesive dressings and other articles having an adhesive layer)
2016-07-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-05-0038220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-09-0084795000Industrial robots, n.e.s.

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded ISOMERASE THERAPEUTICS LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded ISOMERASE THERAPEUTICS LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.